We are live on
!
Find out more
BAM
Broadcrest Asset Management Portfolio holdings
AUM
$44.1M
1-Year Est. Return
4.51%
This Fund
S&P 500
This Quarter
Est. Return
+4.96%
1 Year Est. Return
-4.51%
3 Year Est. Return
+54.14%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$116M
AUM Growth
+$1.32M
(+1.1%)
Cap. Flow
-$3.41M
Cap. Flow
% of AUM
-2.93%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
7
New
–
Increased
2
Reduced
1
Closed
1
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
HEICO Corp Class A
HEI.A
|
+$6.7M |
| 2 |
Bio-Techne
TECH
|
+$4.02M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Otis Worldwide
OTIS
|
+$8.44M |
| 2 |
Enovis
ENOV
|
+$5.69M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Industrials | 48.7% |
| 2 | Healthcare | 34.82% |
| 3 | Technology | 8.95% |
| 4 | Consumer Staples | 7.53% |
Similar funds
MAM
WCPI
NLVP
WAMC
CIEP
IPI
CC
VSAM
Broadcrest Asset Management's Q2 2023 Portfolio in Review
As of Q2 2023, Broadcrest Asset Management held 7 positions worth $116M, up 1.1% from $115M the previous quarter. Its ten largest holdings account for 100% of the portfolio.
Broadcrest Asset Management's Q2 2023 filing shows 2 increased, 1 reduced and 1 closed positions. The largest sale was Otis Worldwide, an estimated $8.44M.
By sector, the portfolio is most concentrated in Industrials at 49% of assets, down from 52% a quarter earlier, followed by Healthcare and Technology.
- Broadcrest Asset Management added most to HEICO Corp Class A in Q2 2023, an estimated $6.7M increase.
- Broadcrest Asset Management's biggest Q2 2023 reduction was Enovis, cutting an estimated $5.69M.
- Broadcrest Asset Management fully exited Otis Worldwide in Q2 2023, selling an estimated $8.44M.
- Broadcrest Asset Management's ten largest holdings make up 100% of its $116M portfolio in Q2 2023.
- Broadcrest Asset Management opened 0 new positions and closed 1 in Q2 2023.
- Broadcrest Asset Management's portfolio value rose 1.1% quarter-over-quarter to $116M.
Based on Broadcrest Asset Management's 13F filing for Q2 2023, filed 10 Aug 2023.